Commentary: infrapopliteal angioplasty with drug-eluting stents: from heart to toe.
Siablis
Dimitris
D
Department of Radiology, Patras University Hospital School of Medicine, Rion, Greece. siablis@upatras.gr
Katsanos
Konstantinos
K
Karnabatidis
Dimitris
D
D000800:Angioplasty, Balloon / Q000295:instrumentation*; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D003251:Constriction, Pathologic; D054855:Drug-Eluting Stents; D006801:Humans; D007511:Ischemia / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D023821:Limb Salvage; D035002:Lower Extremity / Q000098:blood supply*; D011150:Popliteal Artery / Q000503:physiopathology; D011474:Prosthesis Design; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D020123:Sirolimus / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome; D014654:Vascular Patency
D002317:Cardiovascular Agents; D020123:Sirolimus